Maizel Ari
SEC insider (Form 3/4/5 filer). CIK 0002042289. Chief Commercial Officer at Axsome Therapeutics, Inc. (AXSM). 9 reported Form 4/5 transactions since Sep 2024; latest on Apr 22, 2026. Located in NEW YORK, NY.
Companies Maizel Ari has filed insider reports for
- Axsome Therapeutics, Inc. (AXSM): Officer, Chief Commercial Officer
Maizel Ari
CIK: 0002042289
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Axsome Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Apr 22, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect7.5K shares at avg. $70.73$530K - Apr 22, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect7.5K shares at avg. $182.42$1.4M - Apr 21, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectPerformance Stock Units
7.2K shares- - Feb 26, 2026AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
16.4K shares- - Jan 21, 2026AXSM
Axsome Therapeutics, Inc.
SaleDirect7.5K shares at avg. $184.44$1.4M - Jan 21, 2026AXSM
Axsome Therapeutics, Inc.
ExerciseDirect7.5K shares at avg. $70.73$530K - Feb 24, 2025AXSM
Axsome Therapeutics, Inc.
AwardDirectPerformance Stock Units
7.7K shares- - Feb 21, 2025AXSM
Axsome Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
7.8K shares- - Feb 21, 2025AXSM
Axsome Therapeutics, Inc.
AwardDirectRestricted Stock Units
7.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 22, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 7,500 | $70.73 | $530,475 | Direct |
| Apr 22, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 7,500 | $182.42 | $1,368,150 | Direct |
| Apr 21, 2026 | AXSM Axsome Therapeutics, Inc. | Award Performance Stock Units | 7,224 | - | - | Direct |
| Feb 26, 2026 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 16,385 | - | - | Direct |
| Jan 21, 2026 | AXSM Axsome Therapeutics, Inc. | Sale | 7,500 | $184.44 | $1,383,300 | Direct |
| Jan 21, 2026 | AXSM Axsome Therapeutics, Inc. | Exercise | 7,500 | $70.73 | $530,475 | Direct |
| Feb 24, 2025 | AXSM Axsome Therapeutics, Inc. | Award Performance Stock Units | 7,740 | - | - | Direct |
| Feb 21, 2025 | AXSM Axsome Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 7,816 | - | - | Direct |
| Feb 21, 2025 | AXSM Axsome Therapeutics, Inc. | Award Restricted Stock Units | 7,740 | - | - | Direct |
1-9 of 9 transactions